At the end of October, the Department of Labor (“DOL”) released a final rule imposing new disclosure requirements on pharmacy benefit managers (“PBMs”) and certain affiliated brokers and consultants under ERISA Section 408(b)(2). The final rule applies to both future and existing PBM arrangements for plan years starting on or after July 1, 2027.

Separately…

The Second Circuit recently held that in order to state a claim for a prohibited transaction pursuant to ERISA section 406(a)(1)(C), it is not enough to allege that a fiduciary caused the plan to compensate a service provider for its services.  Instead, “the complaint must plausibly allege that the services were unnecessary or involved unreasonable compensation.”  Cunningham v. Cornell Univ., 2023 WL 7504142 (2d Cir. Nov. 14, 2023).  Separately, the Second Circuit affirmed summary judgment for the defendants in connection with the plaintiffs’ fiduciary breach claims that were premised on allegations of excessive recordkeeping fees, underperforming investment funds, and the defendants’ failure to transition to lower-cost share classes of certain mutual funds.